QQQ   304.08 (+0.16%)
AAPL   152.41 (+0.45%)
MSFT   262.76 (+2.33%)
META   186.02 (-0.02%)
GOOGL   103.75 (+0.83%)
AMZN   99.76 (-2.37%)
TSLA   195.85 (+0.56%)
NVDA   212.85 (+0.93%)
NIO   10.90 (-0.27%)
BABA   105.89 (+0.42%)
AMD   83.72 (+0.05%)
T   19.45 (-0.66%)
F   13.11 (-0.23%)
MU   60.12 (+0.23%)
CGC   2.87 (-2.71%)
GE   81.57 (-0.95%)
DIS   109.70 (-0.15%)
AMC   6.64 (-2.35%)
PFE   43.85 (+0.21%)
PYPL   81.89 (-0.53%)
NFLX   357.85 (-1.00%)
QQQ   304.08 (+0.16%)
AAPL   152.41 (+0.45%)
MSFT   262.76 (+2.33%)
META   186.02 (-0.02%)
GOOGL   103.75 (+0.83%)
AMZN   99.76 (-2.37%)
TSLA   195.85 (+0.56%)
NVDA   212.85 (+0.93%)
NIO   10.90 (-0.27%)
BABA   105.89 (+0.42%)
AMD   83.72 (+0.05%)
T   19.45 (-0.66%)
F   13.11 (-0.23%)
MU   60.12 (+0.23%)
CGC   2.87 (-2.71%)
GE   81.57 (-0.95%)
DIS   109.70 (-0.15%)
AMC   6.64 (-2.35%)
PFE   43.85 (+0.21%)
PYPL   81.89 (-0.53%)
NFLX   357.85 (-1.00%)
QQQ   304.08 (+0.16%)
AAPL   152.41 (+0.45%)
MSFT   262.76 (+2.33%)
META   186.02 (-0.02%)
GOOGL   103.75 (+0.83%)
AMZN   99.76 (-2.37%)
TSLA   195.85 (+0.56%)
NVDA   212.85 (+0.93%)
NIO   10.90 (-0.27%)
BABA   105.89 (+0.42%)
AMD   83.72 (+0.05%)
T   19.45 (-0.66%)
F   13.11 (-0.23%)
MU   60.12 (+0.23%)
CGC   2.87 (-2.71%)
GE   81.57 (-0.95%)
DIS   109.70 (-0.15%)
AMC   6.64 (-2.35%)
PFE   43.85 (+0.21%)
PYPL   81.89 (-0.53%)
NFLX   357.85 (-1.00%)
QQQ   304.08 (+0.16%)
AAPL   152.41 (+0.45%)
MSFT   262.76 (+2.33%)
META   186.02 (-0.02%)
GOOGL   103.75 (+0.83%)
AMZN   99.76 (-2.37%)
TSLA   195.85 (+0.56%)
NVDA   212.85 (+0.93%)
NIO   10.90 (-0.27%)
BABA   105.89 (+0.42%)
AMD   83.72 (+0.05%)
T   19.45 (-0.66%)
F   13.11 (-0.23%)
MU   60.12 (+0.23%)
CGC   2.87 (-2.71%)
GE   81.57 (-0.95%)
DIS   109.70 (-0.15%)
AMC   6.64 (-2.35%)
PFE   43.85 (+0.21%)
PYPL   81.89 (-0.53%)
NFLX   357.85 (-1.00%)
NYSE:SNN

Smith & Nephew - SNN Stock Forecast, Price & News

$28.35
+0.03 (+0.11%)
(As of 02/7/2023 09:39 AM ET)
Add
Compare
Today's Range
$28.29
$28.35
50-Day Range
$26.03
$29.02
52-Week Range
$21.77
$36.14
Volume
13,444 shs
Average Volume
648,194 shs
Market Capitalization
$12.34 billion
P/E Ratio
N/A
Dividend Yield
1.93%
Price Target
N/A

Smith & Nephew MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.59% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.68mentions of Smith & Nephew in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.28%
From $1.57 to $1.70 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

920th out of 1,027 stocks

Surgical Appliances & Supplies Industry

21st out of 23 stocks

SNN stock logo

About Smith & Nephew (NYSE:SNN) Stock

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in Watford, the United Kingdom.

Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Stock News Headlines

Smith & Nephew falls Thursday, underperforms market
GRAPHITE: "Essential for America's National Defense"
Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider.
10 Best International Stocks to Buy Now
Smith & Nephew: Still A Buy Despite Short-Term Challenges
GRAPHITE: "Essential for America's National Defense"
Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider.
Smith & Nephew reports Q1 results
Top investment tips for a stocks and shares ISA
See More Headlines
Receive SNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Smith & Nephew and its competitors with MarketBeat's FREE daily newsletter.

SNN Company Calendar

Last Earnings
11/17/2014
Today
2/07/2023
Next Earnings (Estimated)
2/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Employees
18,000
Year Founded
1856

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.21 billion
Cash Flow
$2.85 per share
Book Value
$12.66 per share

Miscellaneous

Free Float
430,995,000
Market Cap
$12.34 billion
Optionable
Optionable
Beta
0.59

Social Links


Key Executives

  • Deepak S Nath
    Chief Executive Officer & Director
  • Paul Connolly
    President-Global Operations
  • Anne-Francoise Nesmes
    Chief Financial Officer & Executive Director
  • Ian Melling
    Senior Vice President-Corporate Finance
  • Alison Parkes
    Chief Compliance Officer













SNN Stock - Frequently Asked Questions

Should I buy or sell Smith & Nephew stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SNN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNN, but not buy additional shares or sell existing shares.
View SNN analyst ratings
or view top-rated stocks.

How have SNN shares performed in 2023?

Smith & Nephew's stock was trading at $26.89 at the beginning of 2023. Since then, SNN shares have increased by 5.3% and is now trading at $28.32.
View the best growth stocks for 2023 here
.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a increase in short interest in the month of January. As of January 15th, there was short interest totaling 2,550,000 shares, an increase of 30.8% from the December 31st total of 1,950,000 shares. Based on an average daily volume of 808,400 shares, the days-to-cover ratio is currently 3.2 days. Currently, 0.6% of the company's shares are short sold.
View Smith & Nephew's Short Interest
.

When is Smith & Nephew's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our SNN earnings forecast
.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) released its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating analysts' consensus estimates of $0.39 by $0.59.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a semi-annual dividend on Monday, August 1st. Stockholders of record on Friday, September 30th will be paid a dividend of $0.288 per share on Wednesday, October 26th. This represents a dividend yield of 2.8%. The ex-dividend date is Thursday, September 29th.
Read our dividend analysis for SNN
.

Is Smith & Nephew a good dividend stock?

Smith & Nephew (NYSE:SNN) pays an annual dividend of $0.55 per share and currently has a dividend yield of 1.93%.
Read our dividend analysis for SNN.

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Scharf Investments LLC (0.48%), Bank of Montreal Can (0.08%), National Bank of Canada FI (0.05%), Clean Yield Group (0.04%), Henry James International Management Inc. (0.04%) and Canvas Wealth Advisors LLC (0.02%).

How do I buy shares of Smith & Nephew?

Shares of SNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $28.32.

How much money does Smith & Nephew make?

Smith & Nephew (NYSE:SNN) has a market capitalization of $12.33 billion and generates $5.21 billion in revenue each year.

How many employees does Smith & Nephew have?

The company employs 18,000 workers across the globe.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The official website for the company is www.smith-nephew.com. The medical equipment provider can be reached via phone at 441923477100, via email at andrew.swift@smith-nephew.com, or via fax at 44-20-7930-3353.

This page (NYSE:SNN) was last updated on 2/7/2023 by MarketBeat.com Staff